Amendments to the Patented Medicines Regulations delayed by a further six months, until January 1, 2022

29 June 2021

According to the Patented Medicine Prices Review Board’s (PMPRB) website, the coming-into-force date of the amended Patented Medicines Regulations (the “Regulations”) has been delayed another six months, until January 1, 2022. The new PMPRB Guidelines, which operationalize the Regulations, are also expected to take effect at the same time.



Initially published in August 2019, this is the third delay in the implementation of the amended Regulations and new PMPRB Guidelines. As previously reported, the coming-into-force date of the amended Regulations was previously delayed until July 1, 2021.

Health Canada has cited the ongoing COVID-19 pandemic and need for additional time for industry to prepare and comply with the changes for the delay.

If you would like to discuss this article further or have any questions, please contact a member of our Life Science Group.


NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.

Related   Life Sciences